查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1787226

全球神经认知评估与復健市场

Neurocognitive Assessment and Rehabilitation
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 269 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球神经认知评估和復健市场规模将达到 217 亿美元

全球神经认知评估与復健市场规模预计在2024年达到146亿美元，预计在2024-2030年的分析期间内将以6.9%的复合年增长率增长，到2030年将达到217亿美元。神经復健治疗是本报告分析的细分领域之一，预计其复合年增长率将达到5.6%，到分析期结束时将达到125亿美元。神经认知评估测试细分领域在分析期间的复合年增长率预计为8.9%。

美国市场规模估计为 40 亿美元，中国市场预计复合年增长率为 10.5%

美国神经认知评估与復健市场规模预计在2024年达到40亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到45亿美元，在2024-2030年的分析期间内，复合年增长率为10.5%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为3.5%和6.6%。在欧洲，预计德国市场的复合年增长率为4.5%。

全球神经认知评估和復健市场—主要趋势和驱动因素摘要

为什么神经认知评估成为现代医疗保健的重要组成部分？

神经认知评估作为诊断、监测和管理不同年龄层和不同医疗条件下认知障碍的关键工具，正迅速获得重要性。这些评估评估记忆力、注意力、执行功能、语言和处理速度等认知功能，帮助医疗保健提供者及早发现神经病变。随着阿兹海默症、帕金森氏症、创伤性脑损伤 (TBI)、中风以及注意力不足过动症和自闭症等神经发育障碍的盛行率不断上升，神经认知测试在临床和研究环境中已变得至关重要。传统的评估方法，包括纸本认知测试和结构化临床访谈，正越来越多地得到提供客观、数据驱动洞察的数位工具的补充。先进的神经影像技术，如功能性磁振造影 (fMRI)、正子断层扫描 (PET) 和脑电图 (EEG)，也被纳入认知评估中，以更深入地了解大脑功能。此外，人工智慧 (AI) 和机器学习在神经认知测试中的应用可以识别传统方法无法检测到的细微认知变化，从而提高诊断的准确性。远端医疗和行动医疗(行动医疗) 应用为无法亲自前往医疗机构的患者提供远距认知筛检，进一步提高了医疗服务的可近性。随着全球人口老化和神经退化性疾病负担的持续加重，对高效、准确、可扩展的神经认知评估解决方案的需求预计将重塑认知医疗的未来。

神经认知復健面临的主要挑战是什么？

儘管取得了显着进展，神经认知復健仍面临许多挑战，影响其有效性和广泛应用。一个主要问题是患者对復健介入措施反应的差异性，因为认知恢復具有高度的个体差异，取决于疾病的严重程度、潜在疾病以及对治疗计划的依从性等因素。此外，获得专业復健服务仍然是一个主要问题，尤其是在神经系统护理基础设施有限的中低收入国家。许多医疗保健系统缺乏训练有素的神经心理学家、治疗师和復健专家，导致认知障碍患者的治疗延迟或治疗效果不佳。另一个重大挑战是缺乏标准化的神经认知復健通讯协定。不同医疗保健提供者的治疗方法存在差异，这使得比较研究和临床结果变得困难。此外，神经復健计画（包括认知治疗课程、辅助科技和家庭復健工具）的高昂费用可能对许多患者构成障碍。认知復健的保险覆盖范围因地区而异，某些保单不涵盖或限制长期神经復健治疗的保险报销。此外，认知復健需要持续的努力，这对于记忆力受损、疲劳和注意力缺陷的患者来说，是一个挑战。应对这些挑战需要多管齐下的方法，包括增加对神经復健研究的投入、改善医疗服务的可近性，以及开发满足不同患者需求的创新且经济高效的解决方案。

科技进步将如何改变神经认知復健？

科技创新正在深刻改变神经认知復健的格局，这些创新提升了认知疗法的有效性、效率和可及性。最具影响力的进展之一是将虚拟实境 (VR) 和扩增实境(AR) 融入认知復健计划，使患者能够参与模拟现实世界认知挑战的身临其境型互动训练练习。这些技术能够提高脑损伤或神经退化性疾病復健患者的记忆力、解决问题和决策能力，提供高度参与和个人化的復健体验。脑机介面 (BCI) 和神经回馈系统的使用也具有突破性意义，它们透过即时监测和调节大脑活动来增强与认知功能相关的神经通路。此外，行动健康应用程式和人工智慧主导的认知训练平台正在彻底改变居家康復，为患者和临床医生提供即时进度跟踪，同时提供游戏化练习，鼓励持续的认知参与。穿戴式生物感测器和智慧型装置透过收集生理和认知数据，进一步增强神经认知康復，从而帮助制定个人化治疗策略。巨量资料分析的兴起也发挥着关键作用，它推动了预测模型的开发，用于评估復健进展并相应地制定干预措施。随着这些创新的不断发展，神经认知復健将变得更加动态、以患者为中心，并能更好地适应个别需求，从而改善长期认知恢復的效果。

是什么推动了神经认知评估和復健市场的成长？

神经认知评估和復健市场的成长受到多种因素的推动，包括神经系统疾病盛行率的上升、数位医疗技术的进步以及对个人化认知復健解决方案日益增长的需求。阿兹海默症和帕金森氏症等神经退化性疾病在全球的增多，加上人口老化，推动了对早期认知评估和长期復健策略的需求。此外，运动员、军人和事故受害者对创伤性脑损伤 (TBI) 影响的认识不断提高，这加速了对高阶认知復健计画的投资。远端医疗和远距医疗服务的扩展也在使神经认知评估工具更易于获取方面发挥关键作用，使患者能够在舒适的家中接受评估和治疗。主导的诊断、数位认知训练平台和穿戴式认知监测设备的日益普及，为临床和家庭认知护理提供了创新解决方案，进一步推动了市场成长。製药业也在促进市场扩张，其正在进行的神经保护和认知增强疗法研究旨在补充復健工作。此外，监管机构对心理健康和认知护理计划的支持正在推动资金和报销政策的製定，鼓励神经认知评估融入主流医疗保健。向数据主导医疗保健和个人化医疗的转变也为精准神经復健创造了机会，精准神经復健可根据个人的认知状况和进展指标量身定制治疗方案。随着这些因素持续影响神经认知评估和復健市场，预计该行业将持续成长，为改善全球个人的认知健康和生活品质提供创新解决方案。

部分

组成部分类型（神经復健治疗、神经认知评估测试）；提供者类型（復健中心、医院和诊所、家庭护理机构、物理治疗中心）

受访公司范例

  • AnthroTronix Inc.
  • BioSensics
  • BrainCheck, Inc.
  • BrainScope Company, Inc.
  • Cambridge Cognition Holdings plc
  • CNS Vital Signs, LLC
  • Cogstate Ltd.
  • Constant Therapy Health
  • Encompass Health
  • Lumos Labs, Inc.（Lumosity）
  • MindMaze
  • NeuroCare Group
  • Neuroelectrics Corporation
  • NeuronUP SL
  • Neurotrack Technologies Inc.
  • Paradigm Healthcare
  • Posit Science Corporation
  • Qbtech AB
  • SCHUHFRIED GmbH
  • XRHealth

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具来改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP32323

Global Neurocognitive Assessment and Rehabilitation Market to Reach US$21.7 Billion by 2030

The global market for Neurocognitive Assessment and Rehabilitation estimated at US$14.6 Billion in the year 2024, is expected to reach US$21.7 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Neurorehabilitation Therapy, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$12.5 Billion by the end of the analysis period. Growth in the Neurocognitive Assessment Testing segment is estimated at 8.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.0 Billion While China is Forecast to Grow at 10.5% CAGR

The Neurocognitive Assessment and Rehabilitation market in the U.S. is estimated at US$4.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.5 Billion by the year 2030 trailing a CAGR of 10.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Neurocognitive Assessment and Rehabilitation Market - Key Trends & Drivers Summarized

Why Is Neurocognitive Assessment Becoming a Crucial Component of Modern Healthcare?

Neurocognitive assessment is rapidly gaining importance as a critical tool for diagnosing, monitoring, and managing cognitive impairments across various age groups and medical conditions. These assessments evaluate cognitive functions such as memory, attention, executive function, language, and processing speed, helping healthcare providers identify neurological disorders at an early stage. With the rising prevalence of conditions like Alzheimer’s disease, Parkinson’s disease, traumatic brain injuries (TBI), stroke, and neurodevelopmental disorders such as ADHD and autism, neurocognitive testing has become indispensable in clinical and research settings. Traditional assessment methods, including paper-based cognitive tests and structured clinical interviews, are being increasingly supplemented by digital tools that offer objective and data-driven insights. Advanced neuroimaging techniques such as functional MRI (fMRI), positron emission tomography (PET), and electroencephalography (EEG) are also being integrated into cognitive assessments, providing a deeper understanding of brain function. Moreover, the adoption of artificial intelligence (AI) and machine learning in neurocognitive testing is enhancing diagnostic accuracy by identifying subtle cognitive changes that may be undetectable through conventional methods. Telemedicine and mobile health (mHealth) applications are further driving accessibility, allowing remote cognitive screening for patients who cannot visit healthcare facilities in person. As the global population ages and the burden of neurodegenerative diseases continues to grow, the demand for efficient, accurate, and scalable neurocognitive assessment solutions is expected to rise, reshaping the future of cognitive healthcare.

What Are the Key Challenges in Neurocognitive Rehabilitation?

Despite significant advancements, neurocognitive rehabilitation faces numerous challenges that impact its effectiveness and widespread adoption. One of the primary concerns is the variability in patient responses to rehabilitation interventions, as cognitive recovery is highly individualized and depends on factors such as the severity of impairment, underlying health conditions, and adherence to treatment plans. Additionally, access to specialized rehabilitation services remains a major issue, particularly in low- and middle-income countries where neurological care infrastructure is limited. Many healthcare systems struggle with a shortage of trained neuropsychologists, therapists, and rehabilitation specialists, leading to delayed or suboptimal treatment for individuals with cognitive impairments. Another critical challenge is the lack of standardized protocols for neurocognitive rehabilitation, as different healthcare providers may use varying therapeutic approaches, making it difficult to compare outcomes across studies and clinical settings. Furthermore, the high cost of neurorehabilitation programs, including cognitive therapy sessions, assistive technologies, and home-based rehabilitation tools, can be a barrier for many patients. Insurance coverage for cognitive rehabilitation varies across regions, with some policies excluding or limiting reimbursements for long-term neurorehabilitation therapies. Additionally, patient engagement and motivation remain significant hurdles, as cognitive rehabilitation requires sustained effort, which can be challenging for individuals experiencing memory deficits, fatigue, or reduced attention spans. Addressing these challenges requires a multi-faceted approach, including increased investment in neurorehabilitation research, improved accessibility to care, and the development of innovative, cost-effective solutions that cater to diverse patient needs.

How Are Technological Advancements Transforming Neurocognitive Rehabilitation?

The landscape of neurocognitive rehabilitation is undergoing a significant transformation, driven by technological innovations that enhance the effectiveness, efficiency, and accessibility of cognitive therapy. One of the most impactful advancements is the integration of virtual reality (VR) and augmented reality (AR) in cognitive rehabilitation programs, allowing patients to engage in immersive, interactive training exercises that simulate real-world cognitive challenges. These technologies provide a highly engaging and personalized rehabilitation experience, improving memory, problem-solving, and decision-making skills in patients recovering from brain injuries or neurodegenerative conditions. Another breakthrough is the use of brain-computer interfaces (BCIs) and neurofeedback systems, which enable real-time monitoring and modulation of brain activity, allowing individuals to strengthen neural pathways associated with cognitive function. Additionally, mobile health applications and AI-driven cognitive training platforms are revolutionizing home-based rehabilitation, offering gamified exercises that encourage continuous cognitive engagement while providing real-time progress tracking for both patients and clinicians. Wearable biosensors and smart devices are further enhancing neurocognitive rehabilitation by collecting physiological and cognitive data that help personalize treatment strategies. The rise of big data analytics is also playing a crucial role, enabling the development of predictive models that assess rehabilitation progress and adjust interventions accordingly. As these technological innovations continue to evolve, neurocognitive rehabilitation is becoming more dynamic, patient-centered, and adaptable to individual needs, leading to improved long-term cognitive recovery outcomes.

What Is Driving the Growth of the Neurocognitive Assessment and Rehabilitation Market?

The growth in the neurocognitive assessment and rehabilitation market is driven by several factors, including the increasing prevalence of neurological disorders, advancements in digital health technologies, and the rising demand for personalized cognitive rehabilitation solutions. The global rise in neurodegenerative diseases such as Alzheimer’s and Parkinson’s, coupled with an aging population, is fueling the demand for early cognitive assessments and long-term rehabilitation strategies. Additionally, the growing awareness of the impact of traumatic brain injuries (TBI) in athletes, military personnel, and accident victims has accelerated investments in advanced cognitive rehabilitation programs. The expansion of telemedicine and remote healthcare services has also played a pivotal role in making neurocognitive assessment tools more accessible, allowing patients to receive evaluations and therapy sessions from the comfort of their homes. The increasing adoption of AI-driven diagnostics, digital cognitive training platforms, and wearable cognitive monitoring devices is further enhancing market growth, providing innovative solutions for both clinical and at-home cognitive care. The pharmaceutical industry is also contributing to market expansion, with ongoing research into neuroprotective drugs and cognitive-enhancing therapeutics aimed at complementing rehabilitation efforts. Moreover, regulatory support for mental health and cognitive care initiatives is driving funding and reimbursement policies that promote the integration of neurocognitive assessment into mainstream healthcare. The shift toward data-driven healthcare and personalized medicine is also creating opportunities for precision neurorehabilitation, where treatment plans are tailored based on individual cognitive profiles and progress metrics. As these factors continue to shape the neurocognitive assessment and rehabilitation market, the industry is expected to witness sustained growth, offering transformative solutions that improve cognitive health and quality of life for individuals worldwide.

SCOPE OF STUDY:

The report analyzes the Neurocognitive Assessment and Rehabilitation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component Type (Neurorehabilitation Therapy, Neurocognitive Assessment Testing); Providers Type (Rehab Centers, Hospital & Clinics, Homecare Settings, Physiotherapy Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • AnthroTronix Inc.
  • BioSensics
  • BrainCheck, Inc.
  • BrainScope Company, Inc.
  • Cambridge Cognition Holdings plc
  • CNS Vital Signs, LLC
  • Cogstate Ltd.
  • Constant Therapy Health
  • Encompass Health
  • Lumos Labs, Inc. (Lumosity)
  • MindMaze
  • NeuroCare Group
  • Neuroelectrics Corporation
  • NeuronUP SL
  • Neurotrack Technologies Inc.
  • Paradigm Healthcare
  • Posit Science Corporation
  • Qbtech AB
  • SCHUHFRIED GmbH
  • XRHealth

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Neurocognitive Assessment and Rehabilitation - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Neurological Disorders Propels Demand for Neurocognitive Assessment Tools
    • Aging Global Population Base Expands Addressable Market Opportunity for Cognitive Rehabilitation Solutions
    • Advancements in Brain-Computer Interface (BCI) Technology Strengthen Business Case for AI-Powered Neurotherapy
    • Integration of Digital Therapeutics and Gamification Drives Patient Engagement and Adoption Rates
    • Shift Toward Remote and Home-Based Healthcare Delivery Models Accelerates Demand for Portable Cognitive Assessment Devices
    • Growing Emphasis on Early Diagnosis of Dementia and Alzheimer's Drives Adoption of Screening Technologies
    • Increasing Use of Wearable Neuro-Monitoring Devices Spurs Growth in Real-Time Cognitive Tracking
    • Rising Investments in Neuroscience Research and Innovation Propels Development of Next-Gen Assessment Platforms
    • Favorable Reimbursement Policies in Developed Markets Sustain Growth Momentum for Cognitive Rehab Services
    • Regulatory Push for Standardization of Neurocognitive Testing Protocols Drives Market Formalization and Expansion
    • Convergence of Neuroimaging and Cognitive Analytics Expands Diagnostic and Rehabilitation Capabilities
    • Growing Application of AI and Machine Learning in Personalized Cognitive Rehabilitation Enhances Market Attractiveness
    • Emergence of VR and AR-Based Cognitive Therapy Solutions Generates High-Value Opportunities for Tech Innovators
    • Rising Adoption of Mental Health and Cognitive Wellness Programs in Corporate Settings Drives Market Penetration
    • Expanding Role of Cognitive Biomarkers in Clinical Trials Bolsters Demand for Digital Cognitive Assessment Tools
    • High Prevalence of Traumatic Brain Injuries Among Military and Sports Personnel Drives Demand for Targeted Rehabilitation Solutions
    • Integration of Cognitive Assessments in Primary Care Settings Broadens Market Reach and Accessibility
    • Public Awareness Campaigns on Cognitive Health and Aging Throw the Spotlight on Preventive Assessment Solutions
    • Rising Demand for Pediatric Cognitive Assessment Tools Driven by Growing Focus on Early Childhood Development
    • Cross-Industry Collaborations Between MedTech, Pharma, and Digital Health Players Accelerate Innovation Cycles
    • Data Privacy and Ethical Concerns Around Neurodata Collection Pose Regulatory Challenges and Impact Market Dynamics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Neurocognitive Assessment and Rehabilitation Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Neurocognitive Assessment and Rehabilitation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Neurorehabilitation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Neurorehabilitation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Neurorehabilitation Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Neurocognitive Assessment Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Neurocognitive Assessment Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Neurocognitive Assessment Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Rehab Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Rehab Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Rehab Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospital & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospital & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Hospital & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Homecare Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Homecare Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Homecare Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Physiotherapy Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Physiotherapy Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Physiotherapy Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • JAPAN
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • CHINA
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • EUROPE
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Neurocognitive Assessment and Rehabilitation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • FRANCE
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • GERMANY
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Neurocognitive Assessment and Rehabilitation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • INDIA
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Neurocognitive Assessment and Rehabilitation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Neurocognitive Assessment and Rehabilitation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030
  • AFRICA
    • Neurocognitive Assessment and Rehabilitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Neurocognitive Assessment and Rehabilitation by Component Type - Neurorehabilitation Therapy and Neurocognitive Assessment Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Component Type - Percentage Breakdown of Value Sales for Neurorehabilitation Therapy and Neurocognitive Assessment Testing for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Neurocognitive Assessment and Rehabilitation by Providers Type - Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Neurocognitive Assessment and Rehabilitation by Providers Type - Percentage Breakdown of Value Sales for Rehab Centers, Hospital & Clinics, Homecare Settings and Physiotherapy Centers for the Years 2015, 2025 & 2030

IV. COMPETITION